Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections

[1]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Dryden.  Complicated skin and soft tissue infection. , 2010, The Journal of antimicrobial chemotherapy.

[3]  A. Goglio,et al.  Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  C. Gentry,et al.  Analysis of Linezolid‐Associated Hematologic Toxicities in a Large Veterans Affairs Medical Center , 2010, Pharmacotherapy.

[5]  G. Drusano,et al.  Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Kaku,et al.  Methicillin resistant Staphylococcus aureus in a Japanese community hospital: 5-year experience , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  Ronald N. Jones,et al.  Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). , 2009, Diagnostic microbiology and infectious disease.

[8]  G. Drusano,et al.  Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  C. Urban,et al.  Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Lamp,et al.  Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy , 2009, The Annals of pharmacotherapy.

[11]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. H. Baltz.  Daptomycin: mechanisms of action and resistance, and biosynthetic engineering. , 2009, Current opinion in chemical biology.

[13]  K. Shimada,et al.  Antimicrobial susceptibility of pathogens isolated from more than 10 000 patients with infectious respiratory diseases: a 25-year longitudinal study , 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[14]  Brian T. Tsuji,et al.  Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. , 2007, Diagnostic microbiology and infectious disease.

[15]  Ronald N. Jones,et al.  Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005) , 2007, BMC infectious diseases.

[16]  Vance G Fowler,et al.  Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. , 2006, The New England journal of medicine.

[17]  R. Arbeit,et al.  The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  H. Shapiro,et al.  Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.

[19]  Steven D. Brown,et al.  In vitro bactericidal activity of daptomycin against staphylococci. , 2002, The Journal of antimicrobial chemotherapy.